Ocular Therapeutix (OCUL) Interest Coverage Ratio (2013 - 2026)

Ocular Therapeutix's Interest Coverage Ratio history runs 14 years deep, the most recent figure standing at 33.61 for Q1 2026.

• On a quarterly basis, Interest Coverage Ratio fell 56.92% year-over-year to 33.61 in Q1 2026; TTM through Mar 2026 was 21.63, a 32.58% decrease from a year earlier, with the FY2025 full-year figure at 0.92, down 21.07% from the prior year.
• Interest Coverage Ratio declined to 33.61 in Q1 2026 per OCUL's latest filing, from 13.81 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 7.37 in Q4 2022 and bottomed at 33.61 in Q1 2026.
• The 5-year median for Interest Coverage Ratio is 12.75 (2023), against an average of 12.87.
• Across the five-year window, Interest Coverage Ratio jumped 168.63% in 2022 and slumped 778.49% in 2025, its largest moves.
• Year by year, Interest Coverage Ratio stood at 7.37 in 2022, then plunged by 132.1% to 2.37 in 2023, then plunged by 588.12% to 16.28 in 2024, then gained by 15.17% to 13.81 in 2025, then sank by 143.32% to 33.61 in 2026.
• Per Business Quant, the three latest OCUL Interest Coverage Ratio figures stand at 33.61 (Q1 2026), 13.81 (Q4 2025), and 22.88 (Q3 2025).